Octagon Capital Advisors LP Apellis Pharmaceuticals, Inc. Transaction History
Octagon Capital Advisors LP
- $449 Million
- Q4 2024
A detailed history of Octagon Capital Advisors LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 3,006,980 shares of APLS stock, worth $72.9 Million. This represents 21.39% of its overall portfolio holdings.
Number of Shares
3,006,980
Previous 3,006,980
-0.0%
Holding current value
$72.9 Million
Previous $86.7 Million
10.64%
% of portfolio
21.39%
Previous 20.95%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
301Shares Held
111MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$297 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$288 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$244 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$234 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$141 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.67B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...